[New aspects on systemic adverse effects of ocular drugs].
Uusitalo
H
H
TAYS:n silmätautien klinikka, Tampere.
Salminen
L
L
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D016907:Adverse Drug Reaction Reporting Systems; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D002319:Cardiovascular System / Q000187:drug effects; D005128:Eye Diseases / Q000188:drug therapy*; D005387:Finland; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009184:Mydriatics / Q000008:administration & dosage / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000009:adverse effects* / Q000493:pharmacokinetics
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D009184:Mydriatics; D009883:Ophthalmic Solutions